JH Teh, A Amgheib, R Fu, C Barnes, J Abrahams… - Pharmaceutics, 2023 - mdpi.com
C-Met is a receptor tyrosine kinase that is overexpressed in a range of different cancer types,
and has been identified as a potential biomarker for cancer imaging and therapy. Previously …